|
IRB Policies
(All forms in PDF format)
Chapter 1: Research Policy Overview
Chapter 2: Governing Principles of the IRB
Chapter 3: Research Approval Process
Chapter 4: Research Non-compliance
Chapter 5: Research Appeal Procedures
Chapter 6: Advisory Review Panel
Chapter 7: IRB and ISRB By-Laws
Chapter 8: Components of Institutional Research Approval
Chapter 9: Types of Human Subjects Research Review
Chapter 10: Continuing Review of Active Research
Chapter 11: Reporting of Adverse Events
Chapter 12: Consent and Assent
Chapter 13: Changing a Protocol and/or Consent Form
Chapter 14: Recruitment and Selection of Human Subjects
Chapter 15: Special Population as Human Research Subjects
Chapter 16: Investigational Drugs
Chapter 17: Drug Handling for Human Research
Chapter 18: Use of Medical Devices for Human Research
Chapter 19: Emergency Use of an Investigational Drug or Device
Chapter 20: Financial Assessment and Cost Monitoring of CAMC Patients as Human Subjects
Chapter 21: Procedures for Purchasing FDA Approved Products
Chapter 22: IRB Certification for Sponsored Research to External Funding Agencies
Chapter 23: Disclosure of Financial Interests Related to Sponsored Research
Chapter 24: Research Ethics
Chapter 25: Guidelines for Conducting Performance Measurements Involving Human Subjects
Central Institutional Review Board (NCI Studies Only)
Deviation Reporting Form
Protocol Deviation/Violation Reporting Procedure
|
